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• Nationally declining cervical cancer rates are 
still high amongst minority women in NJ, with 
Hispanic women being affected the most. 
• The Human Papilloma Virus (HPV) is the most 
common sexually transmitted infection and can 
lead to cervical cancer 
• Administration of the 9-valent HPV vaccine can 
prevent infection and progression to cancer 
• Regular cervical cancer screenings allow for 
better outcomes 
• Various barriers prevent people with a cervix 
receiving the vaccine 
• Various barriers prevent people with a cervix 
aged >/= 30 from receiving regular cervical 
cancer screenings
• Search databases including PubMed and 
SCOPUS for articles spanning from 2016-2020 
• Keywords: Human Papilloma Virus, HPV, HPV 
Vaccine, Gardisil, Barriers to HPV Vaccine, 
New Jersey, cervical cancer, Pap smear
https://www-doh.state.nj.us/doh-shad/indicator/view/CervCancer.RaceEth.html
• Hispanic women are the most likely group to 
lack health coverage, not receive the HPV 
vaccine, not be regularly screened for 
cervical cancer, and die from cervical cancer 
• Uninsured women are less likely receive the 
HPV vaccine and receive regular cervical 
cancer screenings 
• Those who receive early cancer detection 
screenings through the NJCEED program 
are not often tested for HPV
https://www.opendatanetwork.com/entity/0400000US34/New_Jersey/health.health_insurance
HPV Vaccine Uptake: 
• 27% of women aged 21-36 report having 
received at least 1 dose of the HPV vaccine 
• Uninsured women are 50% less likely to have 
received the HPV vaccine 
• Those who received the vaccine are 2x more 
likely to be up to date on cervical cancer 
screenings 
• Women who received a strong physician 
recommendation were 4x more likely to receive 
the vaccine
Cervical Cancer Screenings: 
• Women of non-white racial groups are 65% less 
likely to be up to date on cervical cancer 
screenings 
• Of the Hispanic women who received the HPV 
DNA test, 56% tested positive 
• Uninsured women are 50% less likely to be up 
to date on cervical cancer screenings 
• Of the women enrolled in the NJCEED program, 
only 26.6% of eligible, high risk women received 
an HPV DNA test
• Improved physician recommendation is 
required for the HPV vaccine and HPV 
testing 
• Improved outreach to high-risk populations 
is required 
• Education on programs such as NJCEED 
and the National Breast and Cervical 
Cancer Early Detection Program provide 
free screenings for low income and/or 
uninsured individuals 
• Education on free vaccine programs such 
as Vaccines for Children 
Discussion
Conclusions
• Review methodology- not using primary 
data 
• Self reporting
I would like to thank Dr. Baker and the 
RowanSOM library staff for their support and 
guidance throughout this process. 
Incidence Rate of Cervical 
Cancer in NJ by Race
NJ Percent Uninsured by Race
Citations
  
1. Llanos AA, Tsui J, Rotter D, Toler L, Stroup AMJBwsh. Factors associated with high-risk human papillomavirus test utilization and infection: a population-based study of uninsured and 
underinsured women. 2018;18(1):162  
2. Cronin KA, Lake AJ, Scott S, et al. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics. Cancer 2018;124(13):2785-800  
3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: a cancer journal for clinicians 2019;69(1):7-34  
4. Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly 
Report: Recommendations and Reports 2014;63(5):1-30  
5. Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization 
Practices. American Journal of Transplantation 2019;19(11):3202-06  
6. Group FIS. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. New England Journal of Medicine 2007;356(19):1915-27  
7. Olusola P, Banerjee HN, Philley JV, Dasgupta SJC. Human Papilloma Virus-Associated Cervical Cancer and Health Disparities. 2019;8(6):622  
8. Silver MI, Kobrin S. Exacerbating disparities?: Cervical cancer screening and HPV vaccination. Preventive Medicine 2020;130:105902 doi: https://doi.org/10.1016/
j.ypmed.2019.105902[published Online First: Epub Date]|. 
9. Burd EM. Human papillomavirus and cervical cancer. Clinical microbiology reviews 2003;16(1):1-17  
10. Akinlotan M, Bolin JN, Helduser J, Ojinnaka C, Lichorad A, McClellan DJJoch. Cervical cancer screening barriers and risk factor knowledge among uninsured women. 2017;42(4):770-78  
11. Cancer IAfRo. Cervix cancer screening. Cervix cancer screening, 2005:302-02. 
12. Miller KD, Goding Sauer A, Ortiz AP, et al. Cancer statistics for hispanics/latinos, 2018. CA: A Cancer Journal for Clinicians 2018;68(6):425-45  
13. Silvera SAN, Bandera EV, Jones BA, Kaplan AM, Demisse K. Knowledge of, and beliefs about, access to screening facilities and cervical cancer screening behaviors among low-income women 
in New Jersey. Cancer Causes & Control 2020;31(1):43-49 doi: 10.1007/s10552-019-01244-5[published Online First: Epub Date]|. 
14. Radecki Breitkopf C, Finney Rutten LJ, Findley V, et al. Awareness and knowledge of Human Papillomavirus (HPV), HPV-related cancers, and HPV vaccines in an uninsured adult clinic 
population. 2016;5(11):3346-52  
15. Watts L, Joseph N, Velazquez A, et al. Understanding barriers to cervical cancer screening among Hispanic women. American journal of obstetrics and gynecology 2009;201(2):199. e1-99. e8  
16. Boom K, Lopez M, Daheri M, et al. Perspectives on cervical cancer screening and prevention: challenges faced by providers and patients along the Texas–Mexico border. Perspectives in Public 
Health 2019;139(4):199-205  
17. Cartmell KB, Young-Pierce J, McGue S, et al. Barriers, facilitators, and potential strategies for increasing HPV vaccination: A statewide assessment to inform action. 2018;5:21-31  
18. Rosenthal S, Weiss TW, Zimet GD, Ma L, Good M, Vichnin M. Predictors of HPV vaccine uptake among women aged 19–26: importance of a physician's recommendation. Vaccine 
2011;29(5):890-95  
19. Gerend MA, Zapata C, Reyes E. Predictors of human papillomavirus vaccination among daughters of low-income Latina mothers: the role of acculturation. Journal of Adolescent Health 
2013;53(5):623-29  
20. Calderón-Mora J, Ferdous T, Shokar N. HPV Vaccine Beliefs and Correlates of Uptake Among Hispanic Women and Their Children on the US-Mexico Border. Cancer Control 
2020;27(1):1073274820968881  
21. Watts LA, Joseph N, Wallace M, et al. HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women. Gynecologic oncology 2009;112(3):577-82  
22. Niccolai LM, Mehta NR, Hadler JL. Racial/ethnic and poverty disparities in human papillomavirus vaccination completion. American journal of preventive medicine 2011;41(4):428-33  
23. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA: a cancer journal for clinicians 2004;54(2):78-93  
24. Freeman HP, Wingrove BK. Excess cervical cancer mortality: a marker for low access to health care in poor communities. Rockville, MD: National Cancer Institute, Center to reduce cancer 
health disparities 2005;5:5282  
25. Brandt HM, Pierce JY, Crary AJHv, immunotherapeutics. Increasing HPV vaccination through policy for public health benefit. 2016;12(6):1623-25 
